North America Veterinary PoC Diagnostics Market (2026-2031)
The North America Veterinary PoC Diagnostics Market was valued at $568.9 Million in 2026 and projected to reach to $816.5 Million by 2031, representing a compound annual growth rate of 7.5%. North America's veterinary PoC diagnostics market is positioned for steady expansion through 2031, driven by increasing pet ownership, growing consumer spending on animal healthcare, and technological advancements in rapid diagnostic devices.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Veterinary PoC Diagnostics Market Trends and Insights
- In North America, the adoption of rapid diagnostic tools in veterinary clinics and animal hospitals is accelerating, driven by increasing pet ownership, rising demand for immediate diagnostic results, and growing investment in veterinary healthcare infrastructure.
- North America's market benefits from advanced healthcare systems, high pet spending, and strong regulatory frameworks that support innovation in diagnostic technologies. The North America veterinary PoC diagnostics market is characterized by robust competition among established diagnostic manufacturers and emerging technology providers.
- In North America, key growth drivers include the shift toward preventive care, integration of digital health platforms, and expansion of point-of-care testing capabilities across companion animal and livestock sectors.
- North America's market is expected to maintain steady growth through 2031 as veterinary practices increasingly prioritize rapid, cost-effective diagnostic solutions to improve animal health outcomes and operational efficiency..
Key Market Statistics
- CAGR (2026-2031) 7.5% CAGR
- Market Size, 2026 ~USD 568.9 Million
- Forecast, 2031 ~USD 816.5 Million
- Geography North America
North America Veterinary PoC Diagnostics Market Overview
Market Valuation & Growth :
North America's veterinary PoC diagnostics market is valued at $568.9 million in 2026 and is projected to reach $816.5 million by 2031, growing at a CAGR of 7.5%, slightly below the global average of 7.7%.
Pet Ownership Surge :
Rising pet ownership across the US and Canada is driving demand for rapid diagnostic solutions in veterinary clinics, with pet owners increasingly seeking immediate health assessments and faster treatment decisions.
Clinic Adoption Acceleration :
North American veterinary practices are rapidly adopting point-of-care diagnostic tools to improve operational efficiency, reduce turnaround times, and enhance patient outcomes in both companion and exotic animal care.
US Market Dominance :
The United States represents the largest market segment in North America at $730.5 million, accounting for approximately 85% of the regional market, with Canada contributing $86.0 million.
North America Veterinary PoC Diagnostics Market Dynamics
- The region's mature veterinary infrastructure and high adoption rates of innovative healthcare solutions support sustained market growth.
- Veterinary clinics and animal hospitals are increasingly integrating PoC diagnostics to provide same-day results, improving clinical decision-making and patient satisfaction. The market will benefit from rising awareness of preventive care, expansion of veterinary services in underserved areas, and integration of digital health platforms with diagnostic tools.
- Regulatory support and reimbursement policies in the US and Canada further facilitate market penetration.
- However, competition from established diagnostic providers and pricing pressures may moderate growth rates.
- Strategic partnerships between diagnostic manufacturers and veterinary networks will be critical for capturing market share in this competitive landscape..
Related Ecosystem
Key Takeaways
- North America's veterinary PoC diagnostics market is valued at $568.9 million in 2026 and will reach $816.5 million by 2031, growing at a 7.5% CAGR.
- In North America, rapid adoption of point-of-care testing is driven by increased pet ownership, demand for immediate results, and investment in veterinary infrastructure.
- North America's market benefits from advanced healthcare systems, high pet spending, and strong regulatory support for diagnostic innovation.
- North America's veterinary practices are increasingly prioritizing preventive care and digital health integration, fueling demand for PoC diagnostic solutions through 2031.
Veterinary PoC Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | MOLECULAR DIAGNOSTICS (Technology) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 7.7% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 1.19 (2026) |
| Revenue Forecast (Billions) | ~USD 1.72 (2031) |
| Segments Covered | Product, Animal Type, Type, Technology, Livestock Type, Molecular Diagnostics |
North America Veterinary PoC Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Animal Type
- Companion Animals
- Livestock
By Type
- Cat
- Cattle
- Crispr-Based
- Dog
- Horse
- Isothermal Amplification
- Other Companion Animals
- Other Livestock
- Pcr-Based
- Pig
- Poultry
By Technology
- Immunodiagnostics
- Molecular Diagnostics
- Other Technologies
By Livestock Type
- Cattle
- Other Livestock
- Pig
- Poultry
By Molecular Diagnostics
- Crispr-Based
- Isothermal Amplification
- Pcr-Based
Target Audience
- Veterinary Diagnostic Manufacturers : Manufacturers of PoC diagnostic devices need North America-specific market data to understand regional adoption rates, competitive positioning, and growth opportunities in the US and Canadian veterinary markets.
- Veterinary Clinic Operators & Networks : Veterinary practice owners and hospital chains require market insights to justify investments in PoC diagnostic equipment, benchmark operational efficiency gains, and optimize service offerings for pet owners.
- Healthcare Investment & Private Equity Firms : Investors evaluating veterinary healthcare consolidation and diagnostic technology companies need regional market sizing and growth forecasts to assess investment returns and portfolio company valuations in North America.
- Regulatory & Policy Advisors : Regulatory bodies and policy consultants need market data to understand the impact of PoC diagnostics on veterinary care standards, reimbursement policies, and healthcare outcomes across North American jurisdictions.
- Veterinary Pharmaceutical & Supply Distributors : Distributors and supply chain partners require market intelligence on PoC diagnostic adoption in North American clinics to forecast demand, optimize inventory, and develop complementary product offerings.
Key Companies in the North America Veterinary PoC Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| GENERAL ELECTRIC | United States | Public Company | Commercial Engines & Services,Defense & Propulsion Technologies,Additive and Advanced Components, |
| IDEXX LABORATORIES, INC. | United States | Public Company | Companion Animal Group (in-clinic analyzers, reference labs, software, services),Livestock, Poultry and Dairy Diagnostics,Water Quality Products, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| BIONOTE | South Korea | Public Company | Veterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits, |
| BIOMéRIEUX | France | Public Company | Microbiology ID/AST systems (VITEK 2, VITEK MS, VITEK REVEAL, API, ETEST),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Sepsis, immunoassay, and specialty markers (VIDAS, Hybiome CLIA), |
| VIRBAC | France | Public Company | Companion animal parasiticides (e.g., Prevexto),Companion animal chronic-care nutrition (e.g., Vikaly, petfood),Behavior and stress management (Zenidog/Zenifel), |
GENERAL ELECTRIC
General Electric is a publicly traded United States company founded in 1892 that operates with 57,000 employees.
IDEXX LABORATORIES, INC.
IDEXX Laboratories, Inc. is a publicly traded United States company founded in 1983 with 11,000 employees.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a publicly traded United States company founded in 1956 with 125,000 employees.
BIONOTE
BioNote is a publicly traded South Korean company founded in 2003 with 298 employees.
BIOMéRIEUX
bioMérieux is a publicly traded French company founded in 1963 with 14,894 employees.
VIRBAC
Virbac is a publicly traded French company founded in 1968 with 6,442 employees.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 730.5 Million |
| Canada | USD 86 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($568.9M in 2026) and country-level breakdowns for the US and Canada, enabling accurate budget allocation and revenue projections for veterinary diagnostic investments.
- Growth Trajectory & CAGR Analysis : Understand the 7.5% CAGR trajectory through 2031, allowing stakeholders to benchmark performance against regional growth rates and identify expansion opportunities in a maturing market.
- Competitive Landscape Intelligence : Gain insights into market dynamics specific to North America, including adoption patterns in US and Canadian veterinary clinics, competitive positioning, and differentiation strategies for PoC diagnostic providers.
- Pet Ownership & Demand Drivers : Access detailed analysis of North American pet ownership trends, consumer spending behavior, and demand for rapid diagnostics in companion and exotic animal care to inform product development and marketing strategies.
- Strategic Market Entry & Expansion : Leverage country-specific data for Canada ($86.0M) and the US ($730.5M) to develop targeted go-to-market strategies, identify high-growth segments, and prioritize geographic expansion within North America.
Frequently asked questions
What is the current size of the veterinary PoC diagnostics market in North America?
In North America, the veterinary PoC diagnostics market is estimated at $568.9 million in 2026 and is expected to grow to $816.5 million by 2031.
What is the projected growth rate for North America's veterinary PoC diagnostics market?
North America's veterinary PoC diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2031.
What factors are driving growth in North America's veterinary PoC diagnostics market?
In North America, key growth drivers include rising pet ownership, increased demand for rapid diagnostic results, expansion of veterinary healthcare infrastructure, and the shift toward preventive care models.
How is North America's veterinary PoC diagnostics market segmented?
North America's veterinary PoC diagnostics market encompasses companion animal diagnostics, livestock diagnostics, and various testing modalities including immunoassays, molecular tests, and biochemical assays.
What competitive landscape characterizes North America's veterinary PoC diagnostics market?
North America's market features established diagnostic manufacturers competing alongside emerging technology providers, with differentiation based on speed, accuracy, ease of use, and integration with digital health platforms.
RESEARCH METHODOLOGY
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.
Secondary Research
This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; and white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary PoC diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
Primary Research
In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary PoC diagnostics market. Primary sources from the demand side include small and large animal veterinarians, veterinary clinic and hospital owners, managers of livestock farms and dairy operations, directors of veterinary diagnostic laboratories, officials from government animal health and regulatory agencies, and procurement and purchasing teams from veterinary clinics, hospitals, and farm operations.
A breakdown of the primary respondents is provided below:
Breakdown Of Primary Interviews: Supply-Side Participants, By Company Type, Designation, And Region
Note: C-level executives include CEOs, COOs, CTOs, and VPs.
Other designations include sales, marketing, and product managers.
Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the veterinary PoC diagnostics market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Veterinary PoC Diagnostics Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Market Definition
The veterinary PoC diagnostics market comprises products and technologies used for rapid, on-site diagnosis of diseases and health conditions in animals, enabling immediate clinical decision-making without reliance on centralized laboratories. The market includes consumables (such as test kits, cartridges, strips, and reagents) and instruments (including portable analyzers and handheld diagnostic devices) and covers key technologies such as molecular diagnostics (PCR-based, isothermal amplification, and CRISPR-based methods), immunodiagnostics, and other techniques, including clinical chemistry and hematology. It serves both companion animals (dogs, cats, horses, and others) and livestock (cattle, pigs, poultry, and others), with applications spanning infectious disease detection, routine health monitoring, and preventive care across veterinary clinics, farms, and field settings.
Key Stakeholders
- Veterinary PoC diagnostic kit manufacturers
- Molecular diagnostic technology providers & PoC instrument manufacturers
- Reagent & consumable suppliers
- Veterinary clinics & hospitals
- Livestock farms, dairy farms & integrated animal production companies
- Government animal health authorities & surveillance agencies
- Veterinary diagnostic laboratories
- Veterinarians & field-based animal health service providers
- Academic & veterinary research institutions
- Contract manufacturers & OEM partners
- Distributors & regional channel partners
- Market research & consulting firms
- Investors & venture capital firms
Report Objectives
- To define, describe, segment, and forecast the veterinary PoC diagnostics market by product, technology, animal type, and region, in terms of value
- To define, describe, segment, and forecast the veterinary PoC diagnostics market by product and region, in terms of volume
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall veterinary PoC diagnostics market
- To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies2
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the veterinary PoC diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the veterinary PoC diagnostics market and comprehensively analyze their core competencies and market shares
- To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships
1. Micromarkets are defined as the further segments and subsegments of the veterinary PoC diagnostics market included in the report.
2. Core competencies of companies are captured in terms of the key developments and strategies adopted by them to sustain their market positions.
Available customizations:
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of Rest of Europe veterinary PoC diagnostics market into Austria, Finland, Switzerland, and other countries
- Further breakdown of Rest of Latin America veterinary PoC diagnostics market into Colombia, Chile, and other countries
Competitive Landscape Assessment
Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary PoC diagnostics market
- Competitive leadership mapping for established players in the US
Get the Full Veterinary PoC Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Veterinary PoC Diagnostics Market.
- Canada Veterinary PoC Diagnostics Market
- US Veterinary PoC Diagnostics Market
- Germany Veterinary PoC Diagnostics Market
- UK Veterinary PoC Diagnostics Market
- France Veterinary PoC Diagnostics Market
- Italy Veterinary PoC Diagnostics Market
- Spain Veterinary PoC Diagnostics Market
- Netherlands Veterinary PoC Diagnostics Market
- Poland Veterinary PoC Diagnostics Market
- Sweden Veterinary PoC Diagnostics Market
- China Veterinary PoC Diagnostics Market
- Japan Veterinary PoC Diagnostics Market
- India Veterinary PoC Diagnostics Market
- Australia Veterinary PoC Diagnostics Market
- South Korea Veterinary PoC Diagnostics Market
- New Zealand Veterinary PoC Diagnostics Market
- Thailand Veterinary PoC Diagnostics Market
- Brazil Veterinary PoC Diagnostics Market
- Mexico Veterinary PoC Diagnostics Market
- Argentina Veterinary PoC Diagnostics Market
- Rest Of Europe Veterinary PoC Diagnostics Market
- Rest Of Asia Pacific Veterinary PoC Diagnostics Market
- Kingdom Of Saudi Arabia (Ksa) Veterinary PoC Diagnostics Market
- Rest Of GCC Countries Veterinary PoC Diagnostics Market
- Rest Of Latin America Veterinary PoC Diagnostics Market
- United Arab Emirates (UAE) Veterinary PoC Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report